Greg Fralish

Before joining Cato BioVentures, Dr. Fralish worked in the Department of Cell Biology at Duke University Medical Center as an NIH postdoctoral fellow.
His work analyzed the biochemical and cellular mechanisms of 7 transmembrane receptor signaling in multiple contexts (cells, zebrafish and mice).
Dr. Fralish received his Ph.D.
in Biochemistry and Molecular Biology from the University of Georgia.
His doctoral work focused on reproductive endocrinology and involved structurally characterizing large protein-protein complexes (mass spectrometry and x-ray crystallography).
While at Cato, Dr. Fralish has contributed significantly to scientific teams involved with clinical strategy and design, regulatory strategy, FDA meetings, submission of INDs and biomanufacturing.
Dr. Fralish is certified by the Regulatory Affairs Professionals Society.